Hermetica Superfood Encyclopedia
The Short Answer
Beta-Glucuronidase (EC 3.2.1.31) is a hydrolase enzyme that catalyzes the cleavage of β-D-glucuronides, releasing D-glucuronic acid and an aglycone. This involves a retaining SN2 mechanism, essential for deconjugating various toxins, hormones, and drugs.
CategoryEnzyme
GroupEnzyme
Evidence LevelModerate
Primary Keywordglucuronidase enzyme ec 3.2.1.31 benefits
Synergy Pairings4
Glucuronidase Enzyme EC 3.2.1.31 — botanical close-up
Health Benefits
Aids detoxification by hydrolyzing glucuronide conjugates of toxins, hormones, and drugs, facilitating their excretion.
Supports hormone balance by regulating the bioavailability of glucuronidated estrogens and androge.
Enables in-vitro drug metabolism studies by deconjugating glucuronide-bound compounds for analysis.
Facilitates the detection of metabolic and liver disorders in clinical enzyme assays.
Assists in breaking down glucuronide pollutants during wastewater treatment and environmental remediation.
Origin & History
Natural habitat
Glucuronidase (EC 3.2.1.31) is a hydrolase enzyme that cleaves β-D-glucuronic acid residues from glucuronide conjugates, releasing free aglycones and glucuronic acid. Found in the liver, intestines, and microbiota, it plays a vital role in xenobiotic metabolism, hormone regulation, and detoxification processes. Glucuronidase is also widely used in pharmaceutical research, diagnostics, and environmental remediation.
“Traditionally observed in gut microbiota and hepatic systems, glucuronidase has long contributed to metabolic processing and detoxification, central to hormone regulation and xenobiotic clearance. Modern applications now harness this enzyme in diagnostics, therapeutic research, and ecological waste treatment.”Traditional Medicine
Scientific Research
Glucuronidase is supported by extensive research on its role in enterohepatic recirculation, drug deconjugation, and estrogen metabolism. Its activity is validated across pharmaceutical, clinical, and environmental models, highlighting its significance in detoxification pathways.
Preparation & Dosage
Traditional preparation
Pharmaceutical Research
Used in enzyme assays to study phase II drug metabolism and excretion.
Clinical Diagnostics
Detects enzyme activity changes in liver disease and inherited metabolic disorders.
Environmental Applications
Applied in bioreactors or wastewater systems to decompose glucuronide-based waste.
Food & Beverage Processing
Used in plant-based extraction to enhance the release of bound bioactives.
Nutritional Supplements
Included in gut-focused formulations for detoxification and microbiome modulation.
Recommended Dosage
Typically 0.1–1% enzyme concentration, depending on the system and target substrate.
Nutritional Profile
- Substrate Specificity: Targets β-D-glucuronic acid linkages for efficient glucuronide hydrolysis.
- Operational Range: Functions optimally at pH 5.0–7.5 and temperatures of 25–50°C, depending on origin.
- Catalytic Efficiency: Enhances metabolic turnover and detoxification through phase II deconjugation.
- Synergy: Complements sulfatases, cytochrome P450s, and other detoxification enzymes in biotransformation pathways.
How It Works
Mechanism of Action
Beta-Glucuronidase catalyzes the hydrolysis of β-D-glucuronides, cleaving the β-D-glucuronic acid residue from various substrates to release D-glucuronic acid and an aglycone. This reaction occurs via a retaining SN2 mechanism, involving specific residues like Glu540 (nucleophile) and Glu451 (acid/base) in the human enzyme. It acts on a wide range of compounds, including liver-conjugated drugs, dietary xenobiotics, and endogenous molecules such as proteoglycans, facilitating their deconjugation.
Clinical Evidence
Research on β-Glucuronidase is extensive, encompassing studies across pharmaceutical, clinical, and environmental models. These investigations validate its crucial role in processes like enterohepatic recirculation, drug deconjugation, and estrogen metabolism. Clinical and in-vitro studies confirm its ability to hydrolyze glucuronide conjugates, thereby influencing drug bioavailability and supporting the excretion of toxins and hormones. While specific human trial data are not detailed, its enzymatic activity and physiological significance are well-established.
Safety & Interactions
The provided information does not contain specific details regarding the safety profile, potential side effects, known drug interactions, contraindications, or considerations for pregnancy and lactation concerning β-Glucuronidase. For such detailed safety information, comprehensive pharmacological resources should be consulted.
Synergy Stack
Hermetica Formulation Heuristic
Enzymatic cofactor
Hormonal Balance, Detox & Liver
Also Known As
beta-Glucuronidaseglucuronide hydrolase
Frequently Asked Questions
What is β-Glucuronidase?
Beta-Glucuronidase (EC 3.2.1.31) is a hydrolase enzyme that specifically cleaves β-D-glucuronic acid residues from glucuronide conjugates. This process, known as deconjugation, releases free aglycones and D-glucuronic acid.
How does β-Glucuronidase contribute to detoxification?
The enzyme aids detoxification by hydrolyzing glucuronide conjugates of various toxins, drugs, and xenobiotics, which are formed in the liver to make them more water-soluble for excretion. By cleaving these conjugates, it facilitates the elimination of these compounds from the body.
What is the specific mechanism of action for β-Glucuronidase?
β-Glucuronidase catalyzes hydrolysis via a retaining SN2 mechanism. Key residues like Glu540 (nucleophile) and Glu451 (acid/base) in the human enzyme protonate the glycosidic oxygen, leading to an oxocarbenium ion-like transition state, followed by nucleophilic attack and release of the aglycone.
How does β-Glucuronidase affect hormone balance?
It supports hormone balance by regulating the bioavailability of glucuronidated estrogens and androgens. By deconjugating these hormones, β-Glucuronidase can influence their reabsorption and activity, particularly in the enterohepatic recirculation pathway.
What are the primary substrates of β-Glucuronidase?
The enzyme primarily acts on β-D-glucuronides, which include a diverse range of compounds such as dietary xenobiotics, liver-conjugated drugs formed by UDP-glucuronosyltransferases, and endogenous molecules like components of proteoglycans (e.g., heparan and chondroitin sulfate).
Does β-Glucuronidase supplementation interact with common medications?
β-Glucuronidase may enhance the deconjugation and reabsorption of glucuronidated drugs, potentially affecting their bioavailability and therapeutic levels in the bloodstream. This is particularly relevant for medications like acetaminophen, ibuprofen, and certain hormone therapies that undergo glucuronidation as part of their metabolism. Individuals taking prescription medications should consult a healthcare provider before supplementing with glucuronidase enzymes to avoid unintended alterations in drug efficacy or systemic exposure.
What does clinical research show about the effectiveness of β-Glucuronidase supplementation?
While β-Glucuronidase has well-established enzymatic activity in laboratory and clinical diagnostic settings, human clinical trials specifically evaluating supplementation efficacy for detoxification or hormone balance remain limited. Most evidence supporting its use comes from in-vitro studies and mechanistic research rather than large-scale randomized controlled trials in healthy populations. Current research suggests potential benefits for those with impaired glucuronidation capacity, but more rigorous human studies are needed to establish optimal dosing and clinical outcomes.
Who benefits most from β-Glucuronidase supplementation and who should avoid it?
Individuals with genetic variations in UGT (UDP-glucuronosyltransferase) enzymes or those with liver dysfunction may benefit from supplemental glucuronidase to support detoxification pathways. Women concerned with estrogen metabolism and those undergoing metabolic stress from environmental toxin exposure may also find it beneficial. Conversely, people with existing gastrointestinal dysbiosis, those taking hormone medications, or individuals with certain liver conditions should avoid supplementation without medical supervision, as enhanced glucuronide deconjugation could lead to excessive reabsorption of hormones or xenobiotics.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w glucuronidase-enzyme-ec-3-2-1-31 curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
